| Literature DB >> 24949625 |
Anna L Hansell1, Nectarios Rose2, Christine T Cowie3, Elena G Belousova4, Ioannis Bakolis5, Kitty Ng4, Brett G Toelle6, Guy B Marks7.
Abstract
BACKGROUND: Evidence for an association between traffic-related air pollution and allergic disease is inconsistent, possibly because the adverse effects may be limited to susceptible subgroups and these have not been identified. This study examined children in the Childhood Asthma Prevention Study (CAPS), potentially susceptible to air pollution effects because of a family history of asthma.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24949625 PMCID: PMC4064977 DOI: 10.1371/journal.pone.0098978
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Allergic sensitisation, self-reported allergic disease and lung function testing at age eight years.
| Skin prick test >3 mm | Number (%) | n |
| Any of 11 inhalant and food allergens | 173 (45.3%) | 382 |
| Inhalant allergen | 170 (44.5%) | 382 |
| Ingested allergen | 30 (7.9%) | 382 |
| House dust mite (HDM) | 137 (35.9%) | 382 |
| Ryegrass | 69 (18.1%) | 381 |
| Grass mix | 51 (13.4%) | 380 |
| Alternaria tenuis | 43 (9.7%) | 380 |
| Cockroach | 18 (4.7%) | 381 |
| Cat dander | 23 (4.5%) | 382 |
| Aspergillus | 14 (3.7%) | 381 |
| Dog | 2 (0.5%) | 381 |
|
| ||
| Geometric mean total IgE Ku/L (geometric SD) | 113.8 (5.1) | 303 |
| Any of the four specific IgEs measured ≥0.35 kUA/L | 168 (52.7%) | 319 |
| HDM specific IgE≥0.35 kUA/L | 138 (43.1%) | 320 |
| Ryegrass specific IgE≥0.35 kUA/L | 91 (28.4%) | 320 |
| Alternaria tenuis specific IgE≥0.35 kUA/L | 63 (19.8%) | 319 |
| Cat dander specific IgE≥0.35 kUA/L | 29 (9.1%) | 320 |
|
| ||
| Ever doctor-diagnosed asthma | 170 (40.5%) | 419 |
| Wheeze in last 12 months | 114 (27.2%) | 419 |
| Current asthma (wheeze+diagnosis/AHR) | 93 (22.2%) | 419 |
| Current asthma (wheeze+asthma diagnosis) | 91 (21.7%) | 419 |
| Cough in last 12 months | 310 (74.0%) | 419 |
| Cough in last 12 months at least four times | 101 (24.1%) | 419 |
| Poor asthma control at age 8 years | 41 (9.8%) | 419 |
| Ever doctor diagnosed rhinitis | 86 (20.5%) | 419 |
| Current rhinitis symptoms | 110 (26.4%) | 417 |
| Ever doctor diagnosed eczema | 204 (48.7%) | 419 |
| Current eczema | 58 (14.3%) | 405 |
|
| ||
| Geometric mean eNO ppb (geometric SD) | 7.17 (1.98) | 376 |
Any of egg white, egg yolk, salmon, tuna, peanuts, D. Pteronyssinus, cat dander, cockroach, alternaria, rye grass, grass mix, dog hair, aspergillus.
Any of D. Pteronyssinus, cat dander, cockroach, rye grass, grass mix, alternaria, dog hair, aspergillus.
Any of egg white, egg yolk, salmon, tuna, peanuts.
Figure 1Traffic intensity distribution within 75(Figure 1a) and 50 m of home (Figure 1b) for all children with available questionnaire or clinical data, n = 419.
(Overall Sample) Univariate and multivariate logistic regression analysis for allergic sensitisation in relation to weighted road density within 50 m radius of home.
| VARIABLES | N | RR | 95% CI | N | RR | 95% CI |
| Unadjusted | Adjusted | |||||
|
|
| |||||
| House dust mite specific IgE> = 0.35 kUA/L |
|
|
|
|
|
|
| Ryegrass specific IgE> = 0.35 kUA/L | 320 | 1.03 | 0.79–1.36 | 311 | 0.93 | 0.71–1.23 |
| Alternaria specific IgE> = 0.35 kUA/L | 319 | 1.19 | 0.89–1.59 | 310 | 1.07 | 0.78–1.46 |
| Cat dander specific IgE> = 0.35 kUA/L | 320 | 1.49 | 0.99–2.25 | 311 | 1.3 | 0.85–2.00 |
|
| ||||||
| Any | 382 | 1.15 | 0.99–1.33 | 370 | 1.08 | 0.92–1.26 |
| Inhalant allergens |
|
|
| 370 | 1.1 | 0.95–1.29 |
| Ingested allergens | 382 | 1.1 | 0.72–1.69 | 370 | 0.95 | 0.58–1.57 |
| House dust mite |
|
|
|
|
|
|
| Ryegrass | 381 | 1.17 | 0.87–1.58 | 370 | 0.97 | 0.72–1.32 |
| Grass mix | 380 | 1.25 | 0.88–1.78 | 369 | 1.09 | 0.77–1.55 |
| Alternaria | 380 | 1.08 | 0.71–1.64 | 369 | 0.87 | 0.53–1.42 |
| Cockroach | 381 | 0.92 | 0.46–1.82 | 370 | 0.77 | 0.33–1.79 |
| Cat dander | 382 | 1.35 | 0.82–2.22 | 370 | 1.15 | 0.63–2.11 |
| Aspergillus | 381 | 0.69 | 0.32–1.51 | 370 | 0.69 | 0.27–1.76 |
Relative Risks (RRs) expressed per unit increase in weighted road density variable, where one unit relates to 100 m local road or 33.3 m of motorway within given radius of the home.
RR is the Relative Risk per unit increase in weighted road density from Poisson regression with robust standard errors conducted on binary variables.
Multivariate analyses are adjusted for sex, father's education, mother's education, environmental tobacco smoke exposure, breastfed to 6 months, any dog owned by 8 years, any cat owned by 8 years, maternal smoking in pregnancy, gas cooking at home.
(Overall Sample) Univariate and multivariate linear regression for spirometry and total IgE (kU/L) and Poisson regression with robust standard error analyses for AHR, eNO, questionnaire outcomes (all) in relation to weighted road density within 50 m radius of home.
| Variables | Unadjusted | Adjusted | ||||||
| N | Percent difference (B) | 95% CI | p-value interaction term with atopy | N | Percent difference (B) | 95% CI | p-value interaction term with atopy | |
|
| ||||||||
| Total IgE (k | 303 | 27.39 | −6.40–73.38 | - | 294 | 25.41 | −9.41–73.60 |
|
|
| ||||||||
| FEV1 pre bronchodilator (L) | 397 | −0.66 | −2.37–1.07 | 0.914 | 392 | −0.59 | −2.35–1.20 | 0.515 |
| FEV1 post bronchodilator (L) | 393 | −0.31 | −1.84–1.25 | 0.456 | 388 | −0.35 | −1.92–1.25 | 0.666 |
| FVC pre bronchodilator (L) | 391 | −0.2 | −1.90–1.52 | 0.7 | 386 | −0.08 | −1.83–1.70 | 0.929 |
| FVC post bronchodilator (L) | 387 | −0.55 | −2.12–1.04 | 0.545 | 382 | −0.46 | −2.06–1.15 | 0.571 |
| FEV1/FVC ratio pre bronchodilator | 391 | −0.54 | −1.67–0.61 | 0.979 | 386 | −0.61 | −1.79–0.59 | 0.316 |
| FEV1/FVC ratio post bronchodilator | 387 | 0.17 | −0.68–1.02 | 0.634 | 382 | −0.01 | −0.88–0.87 | 0.99 |
| pre Peak Expiratory Flow (PEF) | 268 | −1.14 | −4.68–2.54 | 0.429 | 265 | −2.09 | −5.81–1.78 | 0.284 |
| post Peak Expiratory Flow (PEF) | 264 | −1.78 | −5.21–1.77 | 0.444 | 261 | −2.28 | −5.86–1.45 | 0.226 |
| Pre forced expiratory flow at 50% vital capacity (FEF50) | 268 | −0.19 | −5.09–4.97 | 0.567 | 265 | −2.02 | −7.03–3.26 | 0.445 |
| Post forced expiratory flow at 50% vital capacity(FEF50) | 264 | −2.84 | −6.72–1.21 | 0.271 | 261 | −4.11 | −8.06–0.01 | 0.0504 |
| Pre forced expiratory flow at mid-expiratory phase(FEF25–75) | 268 | −0.95 | −4.93–3.19 | 0.48 | 265 | −2.33 | −6.45–1.97 | 0.282 |
| Post forced expiratory flow at mid-expiratory phase(FEF25–75) | 264 | −2.27 | −5.75–1.34 | 0.393 | 261 | −3.06 | −6.63–0.65 | 0.105 |
|
|
| |||||||
| eNO ppb † | 376 | 1.02 | 0.96–1.06 | 0.94 | 364 | 1.04 | 0.97–1.07 | 0.923 |
| AHR (yes/no) | 332 | 0.96 | 0.62–1.48 |
| 321 | 0.95 | 0.63–1.41 |
|
|
|
|
| ||||||
| Ever doctor-diagnosed asthma | 419 | 1.09 | 0.92–1.28 | 0.201 | 398 | 1.04 | 0.87–1.23 | 0.265 |
| Wheeze in last 12 months | 419 | 1.19 | 0.96–1.47 | 0.24 | 398 | 1.12 | 0.90–1.39 | 0.251 |
| Cough in last 12 months | 419 | 1.03 | 0.94–1.12 | 0.311 | 398 | 1.02 | 0.94–1.12 | 0.346 |
| Cough more than 4 times in last 12 months | 419 | 1.19 | 0.94–1.50 | 0.226 | 398 | 1.18 | 0.93–1.49 | 0.226 |
| Current asthma (wheeze+diagnosis/AHR) | 419 | 1.2 | 0.94–1.54 | 0.469 | 398 | 1.12 | 0.87–1.45 | 0.546 |
| Current asthma (wheeze+asthma diagnosis) | 419 | 1.22 | 0.95–1.56 | 0.485 | 398 | 1.13 | 0.87–1.46 | 0.539 |
| Poor asthma control | 419 | 1.3 | 0.87–1.95 | 0.885 | 398 | 1.32 | 0.92–1.89 | 0.971 |
| Ever doctor-diagnosed rhinitis |
|
|
| 0.897 |
|
|
| 0.825 |
| Current rhinitis symptoms | 417 | 1.21 | 0.97–1.50 | 0.0856 | 397 | 1.18 | 0.95–1.47 | 0.156 |
| Ever doctor-diagnosed eczema | 419 | 1.11 | 0.96–1.27 | 0.565 | 398 | 1.11 | 0.96–1.28 | 0.424 |
| Current eczema | 405 | 1.30 | 0.98–1.74 | 0.358 | 392 | 1.17 | 0.86–1.61 | 0.333 |
Relative Risks (RRs) and percent difference (B) expressed per unit increase in weighted road density variable, where one unit relates to 100 m local road or 33.3 m of motorway within given radius of the home.
Lung function variables are logged, therefore percent differences by B = 100(eβ−1) are presented for each unit increase in weighted road density, where β is the regression coefficient from linear regression analyses for continuous variables.
RR is the Relative Risk per unit increase in weighted road density from Poisson regression with robust standard errors conducted on binary variables.
Multivariate analyses are adjusted for sex, father's education, mother's education, environmental tobacco smoke exposure, breastfed to 6 months, any dog owned by 8 years, any cat owned by 8 years, maternal smoking in pregnancy, gas cooking at home. Univariate and multivariate lung function analyses included adjustment for age, height and weight.
p-value from additional analysis where an interaction term of weighted road density and atopy was included in the model.
Figure 2Relative risks and 95% confidence intervals from multivariate analysis of allergic sensitisation in relation to weighted road density within 75 m radius and 50 m radius of home.
RRs expressed per unit increase in weighted road density variable, where one unit relates to 100's education, mother's education, environmental tobacco smoke exposure, breastfed to 6 months, any dog owned by 8 years, any cat owned by 8 years, maternal smoking in pregnancy, gas cooking at home.
Figure 3Percent difference and 95% confidence intervals from multivariate analysis of lung function and flow variables in relation to weighted road density within 75 m radius and 50 m radius of home.
Percent difference expressed per unit increase in weighted road density variable, where one unit relates to 100